At a glance
ClinicalIndex Comparison RecordN/ACompleted· 115 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Visceral Lymphatic Mapping Project: A Pilot Study
In Brief
An observational study for Colorectal Cancer and 4 related conditions. Completed, enrolled 115 participants across 1 site.
Detailed Summary
RATIONALE: Diagnostic procedures, such as visceral lymphatic mapping using isosulfan blue, may help find cancer of the pancreas, colon, stomach, small intestine, or gallbladder and find out how far the disease has spread. PURPOSE: This clinical trial is studying the side effects and how well visceral lymphatic mapping using isosulfan blue works in patients with cancer of the pancreas, colon, stomach, small intestine, or gallbladder.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsColorectal Cancer, Gallbladder Cancer, Gastric Cancer, Pancreatic Cancer, Small Intestine Cancer
CountriesUnited States
CollaboratorsNational Cancer Institute (NCI)
Timeline
N/ACompletedFinished
19992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartFeb 1999
First PostedJun 2007
Primary CompletionJun 2009
Study CompletionAug 2010
TodayJul 2026
First PostedJun 21, 2007
Enrollment StartFeb 1, 1999
Primary CompletionJun 1, 2009
Study CompletionAug 1, 2010
TodayJul 2, 2026
Enrollment to primary: 10.3 yearsPosted 19.0 years ago